Zevra Therapeutics (ZVRA) Q3 2025 Earnings

12AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.69
0.29
1.28
2.26

Details

Expected EPS
2.264
Actual EPS
1.21
Surprise EPS
-1.05
Surprise Percent
+46.55%

Description

Zevra Therapeutics (ZVRA) has reported earnings of 1.21 per share for Q3 2025.

0 Comments

Share your thoughts